On May 15, 2026, Balyasny Asset Management L.P. (BAM) filed a Schedule 13G regarding its stake in Rezolute, Inc. (RZLT). As of the event date on March 31, 2026, the reporting persons—including BAM, BAM GP LLC, Balyasny Asset Management Holdings LP, Dames GP LLC, and Dmitry Balyasny—collectively reported beneficial owne...

On May 15, 2026, Westchester Capital Management, LLC, filed a Schedule 13G reporting a new 7.77% stake in Ribbon Acquisition Corporation (RIBB). The filing was made jointly with Westchester Capital Partners, LLC, Virtus Investment Advisers, LLC, and The Merger Fund. Westchester Capital Management reported beneficial ow...

On May 15, 2026, AQR Capital Management, LLC, along with its affiliates AQR Capital Management Holdings, LLC and AQR Arbitrage, LLC, filed a Schedule 13G regarding their holdings in Rising Dragon Acquisition Corp. (RDAC). The filing reveals that the reporting persons have acquired a beneficial ownership of 347,804 ordi...

Highbridge Capital Management, LLC has filed a Schedule 13G regarding its holdings in Roman DBDR Acquisition Corp. II (DRDB). As of the event date on March 31, 2026, the reporting person disclosed a new position consisting of 1,719,358 Class A Ordinary Shares. This represents a 7.5% ownership stake in the company, base...

Balyasny Asset Management L.P. (BAM) and its affiliated reporting persons, including Dmitry Balyasny, have filed a Schedule 13G indicating a significant new position in SAB Biotherapeutics, Inc. (SABS). As of March 31, 2026, the reporting persons collectively beneficially own 5,089,939 shares of common stock, represent...

On May 15, 2026, Caligan Partners LP and its Managing Partner, David Johnson, filed a Schedule 13G disclosing a significant new ownership stake in SAB Biotherapeutics, Inc. (SABS). The reporting persons acquired 7,697,207 shares of Common Stock, representing 10.4% of the company's outstanding shares based on 76,464,094...

On May 15, 2026, Armistice Capital, LLC and its managing member Steven Boyd filed a Schedule 13G disclosing a significant new position in Sangamo Therapeutics, Inc. (SGMO). As of the event date of March 31, 2026, the reporting persons beneficially own 40,400,067 shares of common stock, representing a 9.75% ownership st...

Anson Funds Management LP, along with its affiliates and principals, has filed a Schedule 13G indicating a new substantial ownership stake in SEALSQ Corp (LAES). As of the event date on March 31, 2026, the reporting group collectively beneficially owns 12,457,698 ordinary shares, representing 5.6% of the company's outs...

Wellington Management Group LLP, along with its subsidiaries Wellington Group Holdings LLP and Wellington Investment Advisors Holdings LLP, filed a Schedule 13G on May 15, 2026, reporting a new 5.4% stake in SK Telecom Co., Ltd. (SKM). The filers reported beneficial ownership of 11,598,806 shares of common stock as of ...

On May 15, 2026, Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, filed a Schedule 13G disclosing a new ownership stake in SKYX Platforms Corp. (SKYX). As of the event date on March 31, 2026, the reporting persons beneficially own 7,688,950 shares of common stock, representing 5.77% of ...

On May 15, 2026, Cohen & Steers, Inc. filed a Schedule 13G indicating a new substantial passive stake in SL Green Realty Corp (SLG). As of the event date on March 31, 2026, the investment firm and its subsidiaries, including Cohen & Steers Capital Management, Inc., collectively beneficially own 3,714,293 shares of comm...

Canada Pension Plan Investment Board (CPPIB) filed a Schedule 13G on May 15, 2026, reporting a significant new ownership stake in SM Energy Co. As of the event date on March 31, 2026, CPPIB and its wholly owned subsidiary, CPPIB Crestone Peak Resources Canada Inc., beneficially own 14,493,791 shares of Common Stock. Th...

On May 15, 2026, Highbridge Capital Management, LLC filed a Schedule 13G disclosing a new 7.6% ownership stake in SPACSphere Acquisition Corp. (SSAC). The reporting person, acting as an investment adviser to various funds and accounts, reported beneficial ownership of 1,390,123 Class A Ordinary Shares. The event trigge...

Polar Asset Management Partners Inc., a Canadian-based investment fund manager, has filed a Schedule 13G regarding its holdings in SPACSphere Acquisition Corp (SSAC). As of the event date on March 31, 2026, the firm reported a new position consisting of 1,490,000 Class A ordinary shares. This stake represents approxima...

On May 15, 2026, a group of reporting persons led by Dr. Srinivas Akkaraju filed a Schedule 13G regarding their holdings in Sutro Biopharma, Inc. (STRO). The filing reveals that the reporting persons collectively beneficially own 1,062,872 shares of common stock, representing approximately 6.4% of the company based on ...

On May 15, 2026, T. Rowe Price Associates, Inc. filed a Schedule 13G with the SEC, disclosing a significant new ownership position in Samsara Inc. (IOT). As of the event date of March 31, 2026, the investment adviser reported beneficial ownership of 36,680,798 shares of Class A Common Stock. This position represents a ...

Satellos Bioscience Inc. (the 'Issuer') has reported a new beneficial ownership position by a group of reporting persons including Brian Matthew Bloom, Bloom Burton & Co. Inc., and Jolyon David Burton. According to the Schedule 13G filing dated May 13, 2026, the reporting persons collectively hold 1,137,041 common shar...

On May 15, 2026, T. Rowe Price Associates, Inc. filed a Schedule 13G with the SEC, reporting a new significant ownership stake in Sea Ltd (SE). As of the event date on March 31, 2026, the Baltimore-based investment adviser disclosed beneficial ownership of 33,501,136 American Depositary Receipts (ADRs), representing a ...

On May 15, 2026, Gate City Capital Management, LLC, and its managing member Michael Melby filed a Schedule 13G with the SEC, reporting a new 5.4% stake in Seaport Entertainment Group Inc. (SEG). The filing indicates that the reporting persons beneficially own 689,447 shares of Common Stock as of the event date on March...

On May 15, 2026, Caligan Partners LP and David Johnson filed a Schedule 13G disclosing a new 9.4% ownership stake in Sensei Biotherapeutics, Inc. (SNSE). The reporting persons beneficially own 126,002 shares of common stock as of the event date of March 31, 2026. This position is held through Caligan Partners Master Fu...

On May 15, 2026, StemPoint Capital LP, alongside StemPoint Capital Management GP LLC and Michelle Ross, filed a Schedule 13G disclosing a significant new stake in Sensei Biotherapeutics, Inc. (SNSE). The reporting persons collectively reported beneficial ownership of 132,873 shares of Common Stock, representing a 9.9% ...

On May 15, 2026, Millennium Management LLC and its affiliated reporting persons, including Israel A. Englander, filed a Schedule 13G regarding their holdings in Sensei Biotherapeutics, Inc. (SNSE). The filing reveals that as of February 24, 2026, the reporting persons beneficially owned 84,541 shares, representing 6.7%...

AQR Capital Management, LLC, along with its parent holding company AQR Capital Management Holdings, LLC, has filed a Schedule 13G indicating a new significant passive stake in SentinelOne, Inc. (S). As of the event date on March 31, 2026, the reporting entities beneficially own 19,767,721 shares of Class A common stock...

Van Eck Associates Corporation has filed a Schedule 13G disclosing a new ownership position in Sigma Lithium Corp (SGML). As of the event date on March 31, 2026, the investment adviser reported holding 5,705,514 common shares, representing a 5.12% stake in the company. This filing marks an increase from a previous 0% o...

On May 15, 2026, Anson Funds Management LP and its affiliates filed a Schedule 13G reporting a new 7.0% ownership stake in Sono Group N.V. (SSM). The filing group includes Anson Management GP LLC, Tony Moore, Anson Advisors Inc., Amin Nathoo, and Moez Kassam. Collectively, these reporting persons beneficially own 99,78...